April 2023
AAPOS 23 annual meeting- presenting poster with mid term study results
During the 48th annual meeting of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS 23), Dr. Sigal Zmujack’s presented the mid-term results of two new controlled randomized studies evaluating RevitalVision’s efficacy in improving vision in nystagmus and amblyopia patients aged 9-55, which both showed significant anti-suppression effects.
Download the posterJanuary 2023
Narayana Nethralaya Eye Foundation – What & how does my child see Conference
RevitalVision CEO Yair Yahav was a guest speaker at the Narayana Nethralaya Eye Foundation symposium on Amblyopia, Binocular Vision, Cortical Visual Impairment, and Low Vision.
He presented a scientific & clinical review on Optimizing Cortical Visual Functions with RevitalVision.
January 2023
A new published study on RevitalVision treatment
This independent study, which was published in Vision Development and Rehabilitation: COVD’s Digital Journal, evaluated the efficacy of RevitalVision’s perceptual-based vision training program, in improving visual acuity in adult amblyopic individuals beyond occlusion.
Read the full publication (p.260)November22
Margalit Startup City Haifa- Digital Health Accelerator
We are proud to have been selected as one of the companies to participate in Margalit Startup City’s digital health accelerator in Haifa.
Read moreNovember22
Ophthalmology Innovation Source Summit (OIS)
Our CEO Yair Yahave presented at the OIS Israel (Ophthalmology Innovation Source Summit) during the MIXiii Health-Tech.IL conference between 9-10 November at the ICC in Jerusalem.
October 2022
Presenting at the ACADEMY 2022 SAN DIEGO
The American Academy of Optometry’s annual meeting